ConductScience.org, home

Paper29068496

Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk Among Oral Glucocorticoid Users: Three Matched Cohort Analyses.

Amiche MA and 4 others. J Bone Miner Res, 2018. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk Among Oral Glucocorticoid Users: Three Matched Cohort Analyses. Papers, record 29068496. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29068496

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk Among Oral Glucocorticoid Users: Three Matched Cohort Analyses.
PubMed
Journal
J Bone Miner Res
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
2.07
iCite
Revised in PubMed
2019-10-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Amiche MAM Amine
2Lévesque LELinda E
3Gomes TTara
4Adachi JDJonathan D
5Cadarette SMSuzanne M

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DiphosphonatesMajor topic
Fractures, BoneMajor topic
GlucocorticoidsMajor topic
Administration, Oral
Aged
Aged, 80 and over
Cohort Studies
Female
Humans
Male
Risk Factors
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
41954168Underutilization of Osteoporosis Screening in Patients With Severe COPD and Long Term Corticosteroid Use.J Prim Care Community Health2026https://conductscience.org/library/papers/41954168PubMed
41396571Therapeutic Management of Glucocorticoid-Induced Osteoporosis with a Focus on Older Adults: A Narrative Review.Drugs Aging2026https://conductscience.org/library/papers/41396571PubMed
40935429PRevEnting FracturEs in REnal Disease-1 (PREFERRED-1): protocol for a pilot study of a pragmatic, randomised controlled trial of denosumab for the prevention of fragility fractures in haemodialysis.BMJ Open2025https://conductscience.org/library/papers/40935429PubMed
40906172The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose.Osteoporos Int2025https://conductscience.org/library/papers/40906172PubMed
38516640Nationwide prevalence of glucocorticoid prescriptions over 17 years and osteoporosis prevention among long-term users.SAGE Open Med2024https://conductscience.org/library/papers/38516640PubMed
37881495Disturbed bone marrow adiposity in patients with Cushing's syndrome and glucocorticoid- and postmenopausal- induced osteoporosis.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/37881495PubMed
37253115Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?Endocr Rev2023https://conductscience.org/library/papers/37253115PubMed
36961031Comparison of Fracture Identification Using Different Definitions in Healthcare Administrative (Claims) Data.Pharmacy (Basel)2023https://conductscience.org/library/papers/36961031PubMed
36856881Bad to the bones: prescribing of drugs for the prevention and treatment of osteoporosis in patients on chronic glucocorticoids.Arch Osteoporos2023https://conductscience.org/library/papers/36856881PubMed
35757436Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/35757436PubMed
35203613Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice.Biomedicines2022https://conductscience.org/library/papers/35203613PubMed
34975756When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/34975756PubMed
34830959Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review.Cancers (Basel)2021https://conductscience.org/library/papers/34830959PubMed
33803095Duration of Bisphosphonate Drug Holidays in Osteoporosis Patients: A Narrative Review of the Evidence and Considerations for Decision-Making.J Clin Med2021https://conductscience.org/library/papers/33803095PubMed
33415374Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use.Osteoporos Int2021https://conductscience.org/library/papers/33415374PubMed
33080717Meta-regression analysis of the efficacy of alendronate for prevention of glucocorticoid-induced fractures.Medicine (Baltimore)2020https://conductscience.org/library/papers/33080717PubMed
32253606Hesperetin alleviated glucocorticoid-induced inhibition of osteogenic differentiation of BMSCs through regulating the ERK signaling pathway.Med Mol Morphol2021https://conductscience.org/library/papers/32253606PubMed
31565078Glucocorticoid-induced osteoporosis: from clinical trials to clinical practice.Ther Adv Musculoskelet Dis2019https://conductscience.org/library/papers/31565078PubMed
31201710Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis.Drugs2019https://conductscience.org/library/papers/31201710PubMed
29691807Glucocorticoid-induced osteoporosis: an update.Endocrine2018https://conductscience.org/library/papers/29691807PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29068496

GET https://conductscience.org/api/papers/v1/29068496/authors